Prosecution Insights
Last updated: April 19, 2026
Application No. 18/587,088

INITIALIZING MEDICAL DEVICES

Non-Final OA §112
Filed
Feb 26, 2024
Examiner
HULBERT, AMANDA K
Art Unit
3792
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Itamar Medical Ltd.
OA Round
1 (Non-Final)
84%
Grant Probability
Favorable
1-2
OA Rounds
3y 3m
To Grant
88%
With Interview

Examiner Intelligence

Grants 84% — above average
84%
Career Allow Rate
626 granted / 743 resolved
+14.3% vs TC avg
Minimal +4% lift
Without
With
+3.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 3m
Avg Prosecution
32 currently pending
Career history
775
Total Applications
across all art units

Statute-Specific Performance

§101
3.3%
-36.7% vs TC avg
§103
39.3%
-0.7% vs TC avg
§102
27.9%
-12.1% vs TC avg
§112
22.7%
-17.3% vs TC avg
Black line = Tech Center average estimate • Based on career data from 743 resolved cases

Office Action

§112
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Election/Restrictions Claims 148-155 are withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected Group II, there being no allowable generic or linking claim. Election was made without traverse in the reply filed on January 30, 2026. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 136-147 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Claim 136, lines 1-2 recites the phrase “for initializing an uninitialized home sleep apnea medical device.” It is unclear if the “home sleep apnea device is being functionally or positively recited. It is suggested to positively recite the device before connecting it via a wired or wireless connection with the external programming device. Claim 136, lines 5 and 8 recite method steps of “transmitting a voltage-based index value” and “establishing a wireless connection.” These limitations appear to be placing a method step into an apparatus claim. Allowable Subject Matter Claims 136-147 would be allowable if rewritten or amended to overcome the rejection(s) under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), 2nd paragraph, set forth in this Office action. The following is a statement of reasons for the indication of allowable subject matter: The prior art of record does not disclose a programming system specific to an uninitialized home sleep apnea medical device that transmits a voltage-based index value via a wired connection and then establishes a wireless connection based on the index value, along with the other elements of the claims. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Jensen et al. (US 2003/0204213), Lee et al. (US 2004/0215095), Kugler et al. (US 2011/0218409), Cho et al (US 2014/0351832), Lynn (USPN 5,891,023) Any inquiry concerning this communication or earlier communications from the examiner should be directed to Amanda K Hulbert whose telephone number is (571)270-1912. The examiner can normally be reached Monday - Friday 9:00-5:00. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Unsu Jung can be reached at 571-272-8506. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Amanda K Hulbert/Primary Examiner, Art Unit 3792
Read full office action

Prosecution Timeline

Feb 26, 2024
Application Filed
Mar 19, 2026
Non-Final Rejection — §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582832
DEVICE FOR APPLYING MEDICAL AND COSMETIC RADIATION TO A HUMAN BODY OR TO PARTS OF A HUMAN BODY
2y 5m to grant Granted Mar 24, 2026
Patent 12572627
SYSTEMS AND METHODS FOR ENHANCING ANOMALY DETECTION USING A PATTERN DICTIONARY
2y 5m to grant Granted Mar 10, 2026
Patent 12564718
MAGNETIC ELECTRODE COCHLEAR IMPLANT WITH IN-SITU STIMULATION ADJUSTMENTS
2y 5m to grant Granted Mar 03, 2026
Patent 12551700
ADJUSTABLE AURICULAR NERVE STIMULATION DEVICES, AND ASSOCIATED SYSTEMS AND METHODS
2y 5m to grant Granted Feb 17, 2026
Patent 12544575
BIOELECTRIC NEUROMODULATION FOR HEMATOPOIESIS REGULATION DURING CHEMOTHERAPY
2y 5m to grant Granted Feb 10, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
84%
Grant Probability
88%
With Interview (+3.7%)
3y 3m
Median Time to Grant
Low
PTA Risk
Based on 743 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month